Insufficient scRNA-seq data for expression of FNDC5 at single-cell level.
Insufficient scRNA-seq data for expression of FNDC5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 2605.15 | 2545 / 2642 | 99% | 18.87 | 698 / 705 |
adrenal gland | 99% | 1889.14 | 256 / 258 | 93% | 27.57 | 213 / 230 |
liver | 55% | 1047.04 | 124 / 226 | 60% | 24.92 | 244 / 406 |
ovary | 85% | 752.67 | 153 / 180 | 29% | 1.36 | 123 / 430 |
prostate | 41% | 308.43 | 101 / 245 | 60% | 2.71 | 301 / 502 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.43 | 1 / 1 |
muscle | 100% | 8606.51 | 801 / 803 | 0% | 0 | 0 / 0 |
stomach | 82% | 857.28 | 294 / 359 | 17% | 0.99 | 49 / 286 |
heart | 98% | 3276.70 | 844 / 861 | 0% | 0 | 0 / 0 |
thymus | 27% | 130.97 | 174 / 653 | 64% | 4.74 | 390 / 605 |
uterus | 49% | 333.98 | 84 / 170 | 29% | 9.21 | 131 / 459 |
esophagus | 55% | 774.14 | 799 / 1445 | 21% | 0.98 | 38 / 183 |
breast | 19% | 119.08 | 88 / 459 | 34% | 1.65 | 384 / 1118 |
bladder | 19% | 207.48 | 4 / 21 | 27% | 1.96 | 138 / 504 |
lung | 4% | 24.30 | 25 / 578 | 36% | 2.39 | 419 / 1155 |
blood vessel | 34% | 301.92 | 459 / 1335 | 0% | 0 | 0 / 0 |
intestine | 17% | 129.30 | 165 / 966 | 11% | 1.05 | 60 / 527 |
pancreas | 0% | 0 | 0 / 328 | 28% | 1.76 | 50 / 178 |
adipose | 15% | 102.24 | 179 / 1204 | 0% | 0 | 0 / 0 |
kidney | 3% | 14.66 | 3 / 89 | 10% | 0.88 | 91 / 901 |
skin | 2% | 10.48 | 37 / 1809 | 10% | 1.51 | 46 / 472 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.46 | 4 / 45 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.16 | 2 / 29 |
eye | 0% | 0 | 0 / 0 | 4% | 0.36 | 3 / 80 |
peripheral blood | 1% | 6.26 | 9 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0090336 | Biological process | positive regulation of brown fat cell differentiation |
GO_0008150 | Biological process | biological_process |
GO_0014850 | Biological process | response to muscle activity |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005179 | Molecular function | hormone activity |
GO_0003674 | Molecular function | molecular_function |
Gene name | FNDC5 |
Protein name | Fibronectin type III domain-containing protein 5 Fibronectin type III domain containing 5 Fibronectin type III domain-containing protein 5 (Fibronectin type III repeat-containing protein 2) [Cleaved into: Irisin] |
Synonyms | FRCP2 |
Description | FUNCTION: [Irisin]: Contrary to mouse, may not be involved in the beneficial effects of muscular exercise, nor in the induction of browning of human white adipose tissue. . |
Accessions | ENST00000710568.1 A0A0A0MRR6 A0A3B3ITP1 A0AA34QVI5 ENST00000649537.2 ENST00000373471 ENST00000373471.9 [Q8NAU1-1] Q8NAU1 ENST00000496770.1 [Q8NAU1-3] |